Skip to main
AMTX
AMTX logo

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Aemetis Inc. has demonstrated significant revenue growth in its India segment, with revenues increasing from $3 million in Q1 2025 to $12 million in Q2, and further rising to $15 million in Q3 2025, indicating a strong recovery and positive momentum. The company expects this trend to continue with new contracts anticipated in Q4 2025 and into 2026, supporting sustained revenue generation. Furthermore, the current attractive valuation, underscored by a favorable net present value (NPV) analysis, suggests substantial upside potential for investors.

Bears say

Aemetis Inc. has shown a trend of declining revenue estimates, with projections for 2025 reduced from $270 million to $220 million and for 2026 from $400 million to $330 million. The company has also reported negative earnings per share (EPS) figures, with actual EPS for recent quarters coming in worse than both estimates and consensus expectations, indicating persistent financial underperformance. Additionally, as Aemetis continues to struggle with weaker sales and increasing losses, its operational and financial health raises concerns about its future profitability and viability in the renewable fuels market.

Aemetis (AMTX) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Aemetis (AMTX) has a Strong Buy consensus rating as of Dec 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.